NPPA and heart failure: At a higher dose of 100 mg/kg/day for two weeks, gallic acid effectively improved cardiac function by reducing ventricular diameters and restoring FS, while decreasing heart failure markers (ANP and BNP) and regulating hypertrophic gene markers (β-MHC, and α-myosin heavy chain—α-MHC).